Hepatitis C seroprevalence among newly incarcerated inmates in the Texas correctional system

Public Health

Volumn 117, Issue 1, 2003, Pages 43-48

  Baillargeon, J ^a   Wu, H ^b   Kelley, M J ^b,c   Grady, J ^b   Linthicum, L ^c   Dunn, K ^d,e  

^a Mays Cancer Center at UT Health San Antonio   (United States)

^b University of Texas Medical Branch School of Medicine   (United States)

^c Texas Department of Criminal Justice   (United States)

^d UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^e TeleCare International   (United States)

Author keywords

Alternative correctional facility; Epidemiology; Hepatitis C; HIV AIDS; Inmates; Prison

Indexed keywords

HEPATITIS;

ADOLESCENT; ADULT; ARTICLE; CAUCASIAN; CONTROLLED STUDY; DEMOGRAPHY; ETHNIC GROUP; FEMALE; HEPATITIS C; HUMAN; INFECTION RATE; MAJOR CLINICAL STUDY; MALE; NEGRO; POPULATION RESEARCH; PRISONER; PUBLIC HEALTH; RACE DIFFERENCE; SAMPLING; SEROPREVALENCE; UNITED STATES;

EID: 0037224940     PISSN: 00333506     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0033-3506(02)00009-4     Document Type: Article

References (23)

1. Haber P, Parsons S, Harper S, White P, Rawlinson W, Lloyd A. Transmission of hepatitis C within Australian prisons. Med J Austr 1999;171:31-3.
2. Vlahov D, Nelson K, Quinn T, Kendig N. Prevalence and incidence of hepatitis C infection among male inmates in Maryland. Eur J Epidemiol 1993;9:566-9.
3. Ruiz J, Mikanda J. Seroprevalence of HIV, hepatitis B, hepatitis C, and risk behaviors among inmates entering the California correctional system. Sacramento: California Department of Health Services; 1996.
4. Spaulding A, Greene C, Davidson K, Schneidermann M, Rich J. Hepatitis C in state correctional facilities. Prev Med 1999; 29:92-100.
5. Waldrep T, Summers K, Chiliade P. Coinfection with HIV and HCV: more questions than answers. Pharmacotherapy 2000; 20:1499-507.
6. Butler T, Dolan K, Ferson M, McGuinness L, Brown P, Robertson P. Hepatitis B and C in New South Wales prisons: prevalence and risk factors. Med J Aust 1997;166:127-9.
7. Justice TDoC, The 1999 fiscal year statistical report. Austin, TX: Texas Department of Criminal Justice; 2000.
8. Washington O, Mizell L, Becker K. The 1997 annual report to the Governor and the General Assembly: impact incarceration program. Springfield, IL: Illinois Department of Corrections; 1998.
9. O'Leary V, Clear T. Community corrections approaching the 21st century. Washington, DC: The National Institute of Corrections; 1997.
10. Fabelo T. Three-year recidivism tracking of offenders participating in substance abuse treatment programs. Austin, TX: Criminal Justice Policy Council; 1999.
11. Fabelo T. Projected demand for substance abuse felony punishment facility (SAFP) beds. Austin, TX: Criminal Justice Policy Council; 1994.
12. Wu H, Baillargeon J, Grady J, Black SA, Dunn K. HIV seroprevalence among newly incarcerated inmates in the Texas correctional system. Ann Epidemiol 2001;11:342-6.
13. Texas Department of Criminal Justice, The 1999 fiscal year statistical report. Austin, TX: Texas State Department of Criminal Justice; 2000.
14. Texas Department of Criminal Justice, The state jail system today: an update. Austin, TX: Texas State Department of Criminal Justice; 2000.
15. Texas Department of Criminal Justice, Punishment ranges for felony offenses in Texas. Austin, TX: Texas State Department of Criminal Justice; 1999.
16. Alter M, Kruszon-Moran D, Nainan O, McQuillan G, Gao F, Moyer L, Kaslow R, Margolis H. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med 1999;341:556-62.
17. Braithwaite R, Hammet T, Mayberry R. Prison and AIDS: a public health challenge. San Francisco: Joney-Bass Publishers; 1996.
18. Texas Department of Criminal Justice, Substance abuse felony punishment facilities: general information. Austin, TX: Texas Department of Criminal Justice; 1992.
19. Council TCJP, Substance abuse felony punishment facilities: evaluation and recommendation. Austin, TX: Texas Criminal Justice Policy Council; 2000.
20. Bureau USC. County Population Estimates for July 1, 1999, 2000.
21. Pollard RB. Analogy of human immunodeficiency virus to hepatitis C virus: the human immunodeficiency model. Am J Med 1999;107:41S-4S.
22. Singh S, Thappa D, Jaisankar T, Sujatha S. Sexual co-transmission of HIV, hepatitis B, and hepatitis C viruses. Sex Trans Dis 2000;76:317-9.
23. Zylberberg H, Stanislas P. Reciprocal interactions between human immunodeficiency virus and hepatitis C virus infections. Clin Infect Dis 1996;23:1117-25.